FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304820449> ?p ?o ?g. }

• W4304820449 endingPage "103878" @default.
• W4304820449 startingPage "103878" @default.
• W4304820449 abstract "Incarceration is associated with increased risk of hepatitis C virus (HCV) among people who inject drugs (PWID). Mexico's previous attempt in implementing a public health-oriented drug law reform resulted in minimal impact on incarceration among PWID. However, implementation of reforms alongside Mexico's HCV elimination program has the potential to reshape the HCV epidemic among PWID in the next decade. We use data from a cohort of PWID in Tijuana, Mexico, to inform epidemic modeling to assess the contribution of incarceration and fully implemented drug reform on HCV transmission and elimination among PWID.We developed a dynamic, deterministic model of incarceration, HCV transmission and disease progression among PWID. The model was calibrated to data from Tijuana, Mexico, with 90% HCV seroprevalence among 10,000 PWID. We estimated the 10-year population attributable fraction (PAF) of incarceration to HCV incidence among PWID and simulated, from 2022, the potential impact of the following scenarios: 1) decriminalization (80% reduction in incarceration rates); 2) fully implemented drug law reform (decriminalization and diversion to opiate agonist therapy [OAT]); 3) fully implemented drug law reform with HCV treatment (direct-acting antivirals [DAA]). We also assessed the number DAA needed to reach the 80% incidence reduction target by 2030 under these scenarios.Projections suggest a PAF of incarceration to HCV incidence of 5.4% (95% uncertainty interval [UI]:0.6-11.9%) among PWID in Tijuana between 2022-2032. Fully implemented drug reforms could reduce HCV incidence rate by 10.6% (95%UI:3.1-19.2%) across 10 years and reduce the number of DAA required to achieve Mexico's HCV incidence reduction goal by 14.3% (95%UI:5.3-17.1%).Among PWID in Tijuana, Mexico, incarceration remains an important contributor to HCV transmission. Full implementation of public health-oriented drug law reform could play an important role in reducing HCV incidence and improve the feasibility of reaching the HCV incidence elimination target by 2030." @default.
• W4304820449 created "2022-10-13" @default.
• W4304820449 creator A5002616190 @default.
• W4304820449 creator A5004512761 @default.
• W4304820449 creator A5009835885 @default.
• W4304820449 creator A5018970150 @default.
• W4304820449 creator A5026914535 @default.
• W4304820449 creator A5055112896 @default.
• W4304820449 creator A5055449056 @default.
• W4304820449 creator A5071466365 @default.
• W4304820449 creator A5080016477 @default.
• W4304820449 date "2022-12-01" @default.
• W4304820449 modified "2023-10-12" @default.
• W4304820449 title "Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico" @default.
• W4304820449 cites W168810177 @default.
• W4304820449 cites W1823409421 @default.
• W4304820449 cites W1895949411 @default.
• W4304820449 cites W1965862609 @default.
• W4304820449 cites W1980154502 @default.
• W4304820449 cites W1984413237 @default.
• W4304820449 cites W1985982900 @default.
• W4304820449 cites W2044140397 @default.
• W4304820449 cites W2047033934 @default.
• W4304820449 cites W2058200448 @default.
• W4304820449 cites W2063051038 @default.
• W4304820449 cites W2078422452 @default.
• W4304820449 cites W2087625694 @default.
• W4304820449 cites W2118672557 @default.
• W4304820449 cites W2128760899 @default.
• W4304820449 cites W2145987628 @default.
• W4304820449 cites W2147437748 @default.
• W4304820449 cites W2152803686 @default.
• W4304820449 cites W2158806421 @default.
• W4304820449 cites W2166632159 @default.
• W4304820449 cites W2316779137 @default.
• W4304820449 cites W2345197548 @default.
• W4304820449 cites W2461660560 @default.
• W4304820449 cites W2469883028 @default.
• W4304820449 cites W2473174975 @default.
• W4304820449 cites W2578013986 @default.
• W4304820449 cites W2591797736 @default.
• W4304820449 cites W2753609137 @default.
• W4304820449 cites W2765348434 @default.
• W4304820449 cites W2768977550 @default.
• W4304820449 cites W2781627492 @default.
• W4304820449 cites W2782144376 @default.
• W4304820449 cites W2782256918 @default.
• W4304820449 cites W2786754429 @default.
• W4304820449 cites W2806420310 @default.
• W4304820449 cites W2884203623 @default.
• W4304820449 cites W2887969670 @default.
• W4304820449 cites W2940255242 @default.
• W4304820449 cites W2989666081 @default.
• W4304820449 cites W2996039705 @default.
• W4304820449 cites W3011174254 @default.
• W4304820449 cites W3020359399 @default.
• W4304820449 cites W3036470201 @default.
• W4304820449 cites W3045904168 @default.
• W4304820449 cites W3108618663 @default.
• W4304820449 cites W3130589005 @default.
• W4304820449 cites W3132759487 @default.
• W4304820449 cites W3158441635 @default.
• W4304820449 cites W3160958814 @default.
• W4304820449 cites W4200563633 @default.
• W4304820449 cites W4210545259 @default.
• W4304820449 cites W4220945889 @default.
• W4304820449 doi "https://doi.org/10.1016/j.drugpo.2022.103878" @default.
• W4304820449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36242829" @default.
• W4304820449 hasPublicationYear "2022" @default.
• W4304820449 type Work @default.
• W4304820449 citedByCount "1" @default.
• W4304820449 countsByYear W43048204492023 @default.
• W4304820449 crossrefType "journal-article" @default.
• W4304820449 hasAuthorship W4304820449A5002616190 @default.
• W4304820449 hasAuthorship W4304820449A5004512761 @default.
• W4304820449 hasAuthorship W4304820449A5009835885 @default.
• W4304820449 hasAuthorship W4304820449A5018970150 @default.
• W4304820449 hasAuthorship W4304820449A5026914535 @default.
• W4304820449 hasAuthorship W4304820449A5055112896 @default.
• W4304820449 hasAuthorship W4304820449A5055449056 @default.
• W4304820449 hasAuthorship W4304820449A5071466365 @default.
• W4304820449 hasAuthorship W4304820449A5080016477 @default.
• W4304820449 hasConcept C119599485 @default.
• W4304820449 hasConcept C120665830 @default.
• W4304820449 hasConcept C121332964 @default.
• W4304820449 hasConcept C127413603 @default.
• W4304820449 hasConcept C138816342 @default.
• W4304820449 hasConcept C144024400 @default.
• W4304820449 hasConcept C149923435 @default.
• W4304820449 hasConcept C159047783 @default.
• W4304820449 hasConcept C159110408 @default.
• W4304820449 hasConcept C17744445 @default.
• W4304820449 hasConcept C199539241 @default.
• W4304820449 hasConcept C2776455275 @default.
• W4304820449 hasConcept C2776614996 @default.
• W4304820449 hasConcept C2908647359 @default.
• W4304820449 hasConcept C529928208 @default.
• W4304820449 hasConcept C61511704 @default.

• next